RAD — Radiopharm Theranostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$17.10m
- AU$15.31m
- AU$0.29m
Annual cashflow statement for Radiopharm Theranostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Changes in Working Capital | — | 0.009 | 1.7 |
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.033 | -9.91 | -23.2 |
| Capital Expenditures | — | -28.3 | -1.53 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0 | -0.04 | 0 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 0 | -28.4 | -1.53 |
| Financing Cash Flow Items | — | -4.83 | -0.855 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.06 | 65.1 | 9.22 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.027 | 27 | -15.3 |